North America Cell Line Development Market to witness growth of 12.5% by 2024

A comprehensive research study on North America Cell Line Development Market introduced by Graphical Research provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of the market in terms of the demand landscape, driving factors and growth strategies adopted by market players.

Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of cancer incidences will drive North America cell line development market. Rising vaccine production, growth of biotechnology industry and high healthcare expenditure will drive business growth.

Request for a sample of this research report @ https://www.graphicalresearch.com/request/1067/sample

Presence of dominant industry players in U.S. focusing on developing advanced cell line development products coupled with favorable regulatory structure and innovation in development of biologics due to patent expiration will drive North America cell line development market. However, concerns pertaining to stem cell research will hinder industry growth over the forecast timeframe.

Reagent and media product segment accounted for largest market share in 2017 and is estimated to follow similar trend over the coming years due to its numerous applications in development of regenerative medicines, bio production, drug discovery, tissue engineering toxicity testing and research. Non-mammalian source segment will witness considerable growth during the forecast period owing to its noteworthy applications in insecticide screening and toxicology study.

Make an inquiry for purchasing this report @ https://www.graphicalresearch.com/request/1067/inquiry-before-buying

Hybridomas cell line type segment is forecasted to witness robust growth during the forecast timeframe. Hybridoma technology is most widely used process for large scale production of monoclonal antibodies.

The success of monoclonal antibodies in improving quality of life in patients suffering from cancer, autoimmune diseases and anti-inflammatory disorders have led to increased R&D for developing monoclonal antibodies for various critical health conditions will positively impact growth of cell line development market.

Canada cell line development market will grow considerably during the forecast period owing to numerous efforts undertaken by Canadian government to advance stem cell research and development of stable cell lines for bioproduction in the country. Growing awareness about cell-based therapy, innovation in development of biologics and rising prevalence of cancer will stimulate growth of Canada cell line development market.

Browse Complete Report Summary @ https://www.graphicalresearch.com/industry-insights/1067/north-america-cell-line-development-market

Key industry players operating in North America cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXi AppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy.

Industry players are adopting strategies including merger, acquisition and strategic collaboration and partnership to expand their product portfolio as well as augment consumer base in the industry.

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:

Parikhit B.
Corporate sales,
Graphical Research
Email: sales@graphicalresearh.com
Web: www.graphicalresearch.com/

This release was published on openPR.